Medical use of cannabis and cannabinoids

Is the grass always greener?

Thursday, 3 October 2019 | 12.00-13.30 | Hotel Das Alpenhaus

Organised by Trigal Pharma and CannPico

The cannabis plant has been used for medical and recreational purposes across the world for centuries. Today, cannabis and cannabinoid products have found their way into modern medicine and are positioning themselves as alternate avenues of treatment for pain management, drug abuse disorders and a range of other indications like epilepsy, neurodegenerative and psychotic disorders.

With increased use of medical cannabis and cannabinoids comes a need for comprehensive risk-benefit discussions that take into account the state of clinical evidence on both the potential therapeutic value and side effects for patients, as well as the regulatory challenges and implications. As EU Member States implement medical and recreational cannabis policies that often diverge signifcantly from one country to another, and as more people turn to medical cannabis as a treatment option, this session will explore approaches to legislation and regulation across Europe and beyond, and ask: will cannabis products be a transformative force for quality of life in the future, or do the risks and obstacles outweigh the rewards?

Photo Gallery

Speakers & panellists


LIESBETH VANDAM, Head of Sector ‘Support to Policy’, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

PHILIP MCGUIRE, Head of Department of Psychosis Studies, King’s College London

IAN HAMILTON, Senior Lecturer in Addiction and Mental Health, University of York



NATASHA AZZOPARDI-MUSCAT, Consultant, Public Health Medicine, Directorate for Health Information & Research, Malta, & President, European Public Health Association (EUPHA)

Available Biographical Information

NameVandam, Liesbeth
CVDownload PDF
NameMcGuire, Philip
CVDownload PDF
NameHamilton, Ian
CVDownload PDF
NameKruger, Paola
CVDownload PDF
NameAzzopardi-Muscat, Natasha
CVDownload PDF


EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
Bank Salzburger Sparkasse
Kirchplatz, 5630 Bad Hofgastein, Austria